Trademark: 79353559
Word
KYSO ANTIBODIES
Status Date
Tuesday, January 30, 2024
Registration Number
7292381
Registration Date
Tuesday, January 30, 2024
Filing Date
Wednesday, August 10, 2022
Published for Opposition
Tuesday, November 14, 2023
5 Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders
1 Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disorders
45 Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine
42 Medical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of these
Oct 27, 2022
Sn Assigned For Sect 66a Appl From Ib
Oct 28, 2022
New Application Office Supplied Data Entered
Nov 1, 2022
Application Filing Receipt Mailed
Mar 13, 2023
Assigned To Examiner
Mar 14, 2023
Non-Final Action Written
Mar 15, 2023
Non-Final Action (Ib Refusal) Prepared For Review
May 3, 2023
Refusal Processed By Mpu
May 4, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 24, 2023
Refusal Processed By Ib
Sep 15, 2023
Change Of Name/Address Rec'd From Ib
Oct 6, 2023
Teas Response To Office Action Received
Oct 6, 2023
Correspondence Received In Law Office
Oct 7, 2023
Teas/Email Correspondence Entered
Oct 25, 2023
Notification Of Notice Of Publication E-Mailed
Oct 25, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 13, 2023
Notification Processed By Ib
Nov 14, 2023
Published For Opposition
Nov 14, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 15, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 15, 2024
Teas Change Of Domestic Representatives Address
Jan 15, 2024
Teas Change Of Correspondence Received
Jan 30, 2024
Registered-Principal Register
Oct 12, 2023
Approved For Pub - Principal Register
Oct 25, 2023
Notification Of Possible Opposition Sent To Ib
Jan 15, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2024
Notice Of Registration Confirmation Emailed
Apr 30, 2024
Final Disposition Processed
Apr 30, 2024
Final Disposition Notice Created, To Be Sent To Ib
May 1, 2024
Final Disposition Notice Sent To Ib
May 21, 2024
Final Decision Transaction Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
